| Literature DB >> 22055501 |
Karin E Bornfeldt1, Ira Tabas.
Abstract
Progress in preventing atherosclerotic coronary artery disease (CAD) has been stalled by the epidemic of type 2 diabetes. Further advances in this area demand a thorough understanding of how two major features of type 2 diabetes, insulin resistance and hyperglycemia, impact atherosclerosis. Insulin resistance is associated with systemic CAD risk factors, but increasing evidence suggests that defective insulin signaling in atherosclerotic lesional cells also plays an important role. The role of hyperglycemia in CAD associated with type 2 diabetes is less clear. Understanding the mechanisms whereby type 2 diabetes exacerbates CAD offers hope for new therapeutic strategies to prevent and treat atherosclerotic vascular disease. Copyright ÂEntities:
Mesh:
Substances:
Year: 2011 PMID: 22055501 PMCID: PMC3217209 DOI: 10.1016/j.cmet.2011.07.015
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287